NCT04306900 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- Up to 30 days from the last dose of TTX-030, a maximum duration of 2 years of treatment
- Other-event reporting threshold
- 5%
Safety population = all participants who received at least one dose or any partial dose of TTX-030.
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Cohort 1 - Safety Lead-in (TTX-030 + Budigalimab + mFOLFOX6) | 4 / 8 | 8 / 8 | 2 / 8 |
| Cohort 3B - Gastric (TTX-030 + Budigalimab + mFOLFOX6) | 27 / 44 | 43 / 44 | 13 / 44 |
| Cohort 12 - Gastric (Budigalimab + mFOLFOX6) | 16 / 25 | 25 / 25 | 7 / 25 |
| Cohort 3A - Gastric (TTX-030 + mFOLFOX6) | 2 / 6 | 6 / 6 | 2 / 6 |
| Cohort 2 - mCRPC (TTX-030 + Budigalimab + Docetaxel) | 4 / 7 | 7 / 7 | 0 / 7 |
| Cohort 9 - Pancreatic (TTX-030 + Budigalimab + Gemcitabine + Nab-Paclitaxel) | 16 / 28 | 28 / 28 | 11 / 28 |
| Cohort 11 - Pancreatic (TTX-030 + Gemcitabine + Nab-Paclitaxel) | 8 / 17 | 17 / 17 | 8 / 17 |
| Cohort 4 - CRC (TTX-030 + Budigalimab) | 4 / 14 | 14 / 14 | 7 / 14 |
| Cohort 6 - HNSCC (TTX-030 + Budigalimab) | 2 / 5 | 1 / 5 | 2 / 5 |
| Cohort 8 - GEC (TTX-030 + Budigalimab) | 10 / 23 | 23 / 23 | 10 / 23 |
| Cohort 10 - UCC (TTX-030 + Pembrolizumab) | 3 / 8 | 8 / 8 | 2 / 8 |
Serious adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 44
- num Events
- 2
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 28
- num Events
- 1
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Febrile neutropenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 44
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 28
- num Events
- 1
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 17
- num Events
- 1
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Anemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 8
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 44
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 28
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Blood loss anemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 44
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 28
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Thrombocytopenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 44
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 28
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Atrial fibrillation
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Endocrine disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 44
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 28
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 23
- num Events
- 1
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Hypophysitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 44
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 25
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 28
- num Events
- 0
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 17
- num Events
- 1
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Gastric haemorrhage
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 44
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 25
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 28
- num Events
- 1
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 17
- num Events
- 1
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Gastrointestinal haemorrhage
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 44
- num Events
- 0
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 25
- num Events
- 2
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 28
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Obstruction gastric
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 44
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 28
- num Events
- 1
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Small intestinal obstruction
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 44
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 28
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 14
- num Events
- 1
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 23
- num Events
- 1
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Abdominal pain upper
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 44
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 28
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Anal fistula
Other reported adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 11
- num At Risk
- 44
- num Events
- 11
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 25
- num Events
- 1
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 6
- num Events
- 2
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 5
- num At Risk
- 28
- num Events
- 5
- group Id
- EG006
- num Affected
- 3
- num At Risk
- 17
- num Events
- 3
- group Id
- EG007
- num Affected
- 3
- num At Risk
- 14
- num Events
- 3
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 7
- num At Risk
- 23
- num Events
- 7
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Abdominal pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 9
- num At Risk
- 44
- num Events
- 9
- group Id
- EG002
- num Affected
- 5
- num At Risk
- 25
- num Events
- 5
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 7
- num At Risk
- 28
- num Events
- 7
- group Id
- EG006
- num Affected
- 4
- num At Risk
- 17
- num Events
- 4
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Alanine aminotransferase increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Skin and subcutaneous tissue disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 8
- num Events
- 1
- group Id
- EG001
- num Affected
- 5
- num At Risk
- 44
- num Events
- 5
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 25
- num Events
- 1
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 6
- num Events
- 2
- group Id
- EG004
- num Affected
- 5
- num At Risk
- 7
- num Events
- 5
- group Id
- EG005
- num Affected
- 12
- num At Risk
- 28
- num Events
- 12
- group Id
- EG006
- num Affected
- 6
- num At Risk
- 17
- num Events
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Alopecia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 8
- num Events
- 2
- group Id
- EG001
- num Affected
- 9
- num At Risk
- 44
- num Events
- 9
- group Id
- EG002
- num Affected
- 7
- num At Risk
- 25
- num Events
- 7
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 6
- num Events
- 2
- group Id
- EG004
- num Affected
- 2
- num At Risk
- 7
- num Events
- 2
- group Id
- EG005
- num Affected
- 15
- num At Risk
- 28
- num Events
- 15
- group Id
- EG006
- num Affected
- 7
- num At Risk
- 17
- num Events
- 7
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG009
- num Affected
- 4
- num At Risk
- 23
- num Events
- 4
- group Id
- EG010
- num Affected
- 1
- num At Risk
- 8
- num Events
- 1
- term
- Anemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 8
- num At Risk
- 44
- num Events
- 8
- group Id
- EG002
- num Affected
- 5
- num At Risk
- 25
- num Events
- 5
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 9
- num At Risk
- 28
- num Events
- 9
- group Id
- EG006
- num Affected
- 4
- num At Risk
- 17
- num Events
- 4
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Aspartate aminotransferase increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 18
- num At Risk
- 44
- num Events
- 18
- group Id
- EG002
- num Affected
- 5
- num At Risk
- 25
- num Events
- 5
- group Id
- EG003
- num Affected
- 3
- num At Risk
- 6
- num Events
- 3
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- group Id
- EG005
- num Affected
- 6
- num At Risk
- 28
- num Events
- 6
- group Id
- EG006
- num Affected
- 6
- num At Risk
- 17
- num Events
- 6
- group Id
- EG007
- num Affected
- 2
- num At Risk
- 14
- num Events
- 2
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 7
- num At Risk
- 23
- num Events
- 7
- group Id
- EG010
- num Affected
- 1
- num At Risk
- 8
- num Events
- 1
- term
- Constipation
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 7
- num At Risk
- 44
- num Events
- 7
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 25
- num Events
- 3
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 28
- num Events
- 1
- group Id
- EG006
- num Affected
- 2
- num At Risk
- 17
- num Events
- 2
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 14
- num Events
- 1
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 6
- num At Risk
- 23
- num Events
- 6
- group Id
- EG010
- num Affected
- 1
- num At Risk
- 8
- num Events
- 1
- term
- Cough
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 8
- num Events
- 1
- group Id
- EG001
- num Affected
- 10
- num At Risk
- 44
- num Events
- 10
- group Id
- EG002
- num Affected
- 7
- num At Risk
- 25
- num Events
- 7
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG004
- num Affected
- 2
- num At Risk
- 7
- num Events
- 2
- group Id
- EG005
- num Affected
- 3
- num At Risk
- 28
- num Events
- 3
- group Id
- EG006
- num Affected
- 2
- num At Risk
- 17
- num Events
- 2
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- COVID-19
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 8
- num Events
- 1
- group Id
- EG001
- num Affected
- 19
- num At Risk
- 44
- num Events
- 19
- group Id
- EG002
- num Affected
- 8
- num At Risk
- 25
- num Events
- 8
- group Id
- EG003
- num Affected
- 3
- num At Risk
- 6
- num Events
- 3
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 10
- num At Risk
- 28
- num Events
- 10
- group Id
- EG006
- num Affected
- 7
- num At Risk
- 17
- num Events
- 7
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 10
- num At Risk
- 23
- num Events
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Decreased appetite
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 8
- num Events
- 1
- group Id
- EG001
- num Affected
- 19
- num At Risk
- 44
- num Events
- 19
- group Id
- EG002
- num Affected
- 6
- num At Risk
- 25
- num Events
- 6
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 6
- num Events
- 2
- group Id
- EG004
- num Affected
- 2
- num At Risk
- 7
- num Events
- 2
- group Id
- EG005
- num Affected
- 10
- num At Risk
- 28
- num Events
- 10
- group Id
- EG006
- num Affected
- 5
- num At Risk
- 17
- num Events
- 5
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Diarrhea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 44
- num Events
- 3
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG004
- num Affected
- 2
- num At Risk
- 7
- num Events
- 2
- group Id
- EG005
- num Affected
- 8
- num At Risk
- 28
- num Events
- 8
- group Id
- EG006
- num Affected
- 4
- num At Risk
- 17
- num Events
- 4
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 6
- num At Risk
- 23
- num Events
- 6
- group Id
- EG010
- num Affected
- 2
- num At Risk
- 8
- num Events
- 2
- term
- Edema peripheral
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 8
- num Events
- 2
- group Id
- EG001
- num Affected
- 17
- num At Risk
- 44
- num Events
- 17
- group Id
- EG002
- num Affected
- 6
- num At Risk
- 25
- num Events
- 6
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 6
- num Events
- 2
- group Id
- EG004
- num Affected
- 7
- num At Risk
- 7
- num Events
- 7
- group Id
- EG005
- num Affected
- 18
- num At Risk
- 28
- num Events
- 18
- group Id
- EG006
- num Affected
- 11
- num At Risk
- 17
- num Events
- 11
- group Id
- EG007
- num Affected
- 2
- num At Risk
- 14
- num Events
- 2
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 11
- num At Risk
- 23
- num Events
- 11
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Fatigue
Complete source fields
- description
- Safety population = all participants who received at least one dose or any partial dose of TTX-030.
- event Groups
- deaths Num Affected
- 2
- deaths Num At Risk
- 8
- description
- Participants in Cohort 1 were administered IV TTX-030 at a loading dose of 40 mg/kg 7 days before Cycle 1 Day 1 followed by treatment with 20 mg/kg Q2W on Days 1 and 15, plus budigalimab at a dose of 500 mg (Q4W) on Day 1 plus mFOLFOX6 over 48 hours (Q2W) on Day 1 and 15 of each 28-day cycle.
- id
- EG000
- other Num Affected
- 8
- other Num At Risk
- 8
- serious Num Affected
- 4
- serious Num At Risk
- 8
- title
- Cohort 1 - Safety Lead-in (TTX-030 + Budigalimab + mFOLFOX6)
- deaths Num Affected
- 13
- deaths Num At Risk
- 44
- description
- Participants in Cohort 3B were administered IV TTX-030 at a loading dose of 40 mg/kg 7 days before Cycle 1 Day 1 followed by treatment with 20 mg/kg Q2W on Days 1 and 15, plus budigalimab at a dose of 500 mg (Q4W) on Day 1 plus mFOLFOX6 over 48 hours (Q2W) on Day 1 and 15 of each 28-day cycle.
- id
- EG001
- other Num Affected
- 43
- other Num At Risk
- 44
- serious Num Affected
- 27
- serious Num At Risk
- 44
- title
- Cohort 3B - Gastric (TTX-030 + Budigalimab + mFOLFOX6)
- deaths Num Affected
- 7
- deaths Num At Risk
- 25
- description
- Participants in Cohort 12 were administered IV budigalimab at a dose of 500 mg (Q4W) on Day 1 plus mFOLFOX6 over 48 hours (Q2W) on Day 1 and 15 of each 28-day cycle.
- id
- EG002
- other Num Affected
- 25
- other Num At Risk
- 25
- serious Num Affected
- 16
- serious Num At Risk
- 25
- title
- Cohort 12 - Gastric (Budigalimab + mFOLFOX6)
- deaths Num Affected
- 2
- deaths Num At Risk
- 6
- description
- Participants in Cohort 3A were administered IV TTX-030 at a loading dose of 40 mg/kg 7 days before Cycle 1 Day 1 followed by treatment with 20 mg/kg Q2W on Days 1 and 15 plus mFOLFOX6 over 48 hours (Q2W) on Day 1 and 15 of each 28-day cycle.
- id
- EG003
- other Num Affected
- 6
- other Num At Risk
- 6
- serious Num Affected
- 2
- serious Num At Risk
- 6
- title
- Cohort 3A - Gastric (TTX-030 + mFOLFOX6)
- deaths Num Affected
- 0
- deaths Num At Risk
- 7
- description
- Participants in Safety Lead-in Cohort 2 were administered IV TTX-030 at a loading dose of 40 mg/kg 7 days before Cycle 1 Day 1 followed by treatment with 30 mg/kg Q3W plus budigalimab 375 mg Q3W plus docetaxel at a dose of 75 mg/m2 Q3W on Day 1 of each 21-day treatment cycle.
- id
- EG004
- other Num Affected
- 7
- other Num At Risk
- 7
- serious Num Affected
- 4
- serious Num At Risk
- 7
- title
- Cohort 2 - mCRPC (TTX-030 + Budigalimab + Docetaxel)
- deaths Num Affected
- 11
- deaths Num At Risk
- 28
- description
- Participants in Cohort 9 were administered IV TTX-030 at a loading dose of 40 mg/kg 7 days before Cycle 1 Day 1 followed by treatment with 20 mg/kg Q2W on Days 1 and 15 plus budigalimab at a dose of 500 mg (Q4W) on Day 1 plus gemcitabine 1000 mg/m2 + nab-paclitaxel 125 mg/m2 on Days 1, 8, and 15 each 28-day cycle.
- id
- EG005
- other Num Affected
- 28
- other Num At Risk
- 28
- serious Num Affected
- 16
- serious Num At Risk
- 28
- title
- Cohort 9 - Pancreatic (TTX-030 + Budigalimab + Gemcitabine + Nab-Paclitaxel)
- deaths Num Affected
- 8
- deaths Num At Risk
- 17
- description
- Participants in Cohort 11 were administered IV TTX-030 at a loading dose of 40 mg/kg 7 days before Cycle 1 Day 1 followed by treatment with 20 mg/kg Q2W on Days 1 and 15 plus gemcitabine 1000 mg/m2 + nab-paclitaxel 125 mg/m2 on Days 1, 8, and 15 each 28-day cycle.
- id
- EG006
- other Num Affected
- 17
- other Num At Risk
- 17
- serious Num Affected
- 8
- serious Num At Risk
- 17
- title
- Cohort 11 - Pancreatic (TTX-030 + Gemcitabine + Nab-Paclitaxel)
- deaths Num Affected
- 7
- deaths Num At Risk
- 14
- description
- Participants in Cohort 4 were administered IV TTX-030 at a loading dose of 40 mg/kg 7 days before Cycle 1 Day 1 followed by treatment with 30 mg/kg Q3W plus budigalimab at a dose of 375 mg Q3W on Day 1 of each 21-day treatment cycle.
- id
- EG007
- other Num Affected
- 14
- other Num At Risk
- 14
- serious Num Affected
- 4
- serious Num At Risk
- 14
- title
- Cohort 4 - CRC (TTX-030 + Budigalimab)
- deaths Num Affected
- 2
- deaths Num At Risk
- 5
- description
- Participants in Cohort 6 were administered IV TTX-030 at a loading dose of 40 mg/kg 7 days before Cycle 1 Day 1 followed by treatment with 30 mg/kg Q3W plus budigalimab at a dose of 375 mg Q3W on Day 1 of each 21-day treatment cycle.
- id
- EG008
- other Num Affected
- 1
- other Num At Risk
- 5
- serious Num Affected
- 2
- serious Num At Risk
- 5
- title
- Cohort 6 - HNSCC (TTX-030 + Budigalimab)
- deaths Num Affected
- 10
- deaths Num At Risk
- 23
- description
- Participants in Cohort 8 were administered IV TTX-030 at a loading dose of 40 mg/kg 7 days before Cycle 1 Day 1 followed by treatment with 30 mg/kg Q3W plus budigalimab at a dose of 375 mg Q3W on Day 1 of each 21-day treatment cycle.
- id
- EG009
- other Num Affected
- 23
- other Num At Risk
- 23
- serious Num Affected
- 10
- serious Num At Risk
- 23
- title
- Cohort 8 - GEC (TTX-030 + Budigalimab)
- deaths Num Affected
- 2
- deaths Num At Risk
- 8
- description
- Participants in Cohort 10 were administered IV TTX-030 at a loading dose of 40 mg/kg 7 days before Cycle 1 Day 1 followed by treatment with 30 mg/kg Q3W plus pembrolizumab at a dose of 200 mg Q3W on Day 1 of each 21-day treatment cycle.
- id
- EG010
- other Num Affected
- 8
- other Num At Risk
- 8
- serious Num Affected
- 3
- serious Num At Risk
- 8
- title
- Cohort 10 - UCC (TTX-030 + Pembrolizumab)
- frequency Threshold
- 5
- other Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 11
- num At Risk
- 44
- num Events
- 11
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 25
- num Events
- 1
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 6
- num Events
- 2
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 5
- num At Risk
- 28
- num Events
- 5
- group Id
- EG006
- num Affected
- 3
- num At Risk
- 17
- num Events
- 3
- group Id
- EG007
- num Affected
- 3
- num At Risk
- 14
- num Events
- 3
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 7
- num At Risk
- 23
- num Events
- 7
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Abdominal pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 9
- num At Risk
- 44
- num Events
- 9
- group Id
- EG002
- num Affected
- 5
- num At Risk
- 25
- num Events
- 5
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 7
- num At Risk
- 28
- num Events
- 7
- group Id
- EG006
- num Affected
- 4
- num At Risk
- 17
- num Events
- 4
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Alanine aminotransferase increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Skin and subcutaneous tissue disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 8
- num Events
- 1
- group Id
- EG001
- num Affected
- 5
- num At Risk
- 44
- num Events
- 5
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 25
- num Events
- 1
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 6
- num Events
- 2
- group Id
- EG004
- num Affected
- 5
- num At Risk
- 7
- num Events
- 5
- group Id
- EG005
- num Affected
- 12
- num At Risk
- 28
- num Events
- 12
- group Id
- EG006
- num Affected
- 6
- num At Risk
- 17
- num Events
- 6
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Alopecia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 8
- num Events
- 2
- group Id
- EG001
- num Affected
- 9
- num At Risk
- 44
- num Events
- 9
- group Id
- EG002
- num Affected
- 7
- num At Risk
- 25
- num Events
- 7
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 6
- num Events
- 2
- group Id
- EG004
- num Affected
- 2
- num At Risk
- 7
- num Events
- 2
- group Id
- EG005
- num Affected
- 15
- num At Risk
- 28
- num Events
- 15
- group Id
- EG006
- num Affected
- 7
- num At Risk
- 17
- num Events
- 7
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 5
- num Events
- 1
- group Id
- EG009
- num Affected
- 4
- num At Risk
- 23
- num Events
- 4
- group Id
- EG010
- num Affected
- 1
- num At Risk
- 8
- num Events
- 1
- term
- Anemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 8
- num At Risk
- 44
- num Events
- 8
- group Id
- EG002
- num Affected
- 5
- num At Risk
- 25
- num Events
- 5
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 9
- num At Risk
- 28
- num Events
- 9
- group Id
- EG006
- num Affected
- 4
- num At Risk
- 17
- num Events
- 4
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Aspartate aminotransferase increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 18
- num At Risk
- 44
- num Events
- 18
- group Id
- EG002
- num Affected
- 5
- num At Risk
- 25
- num Events
- 5
- group Id
- EG003
- num Affected
- 3
- num At Risk
- 6
- num Events
- 3
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- group Id
- EG005
- num Affected
- 6
- num At Risk
- 28
- num Events
- 6
- group Id
- EG006
- num Affected
- 6
- num At Risk
- 17
- num Events
- 6
- group Id
- EG007
- num Affected
- 2
- num At Risk
- 14
- num Events
- 2
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 7
- num At Risk
- 23
- num Events
- 7
- group Id
- EG010
- num Affected
- 1
- num At Risk
- 8
- num Events
- 1
- term
- Constipation
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 7
- num At Risk
- 44
- num Events
- 7
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 25
- num Events
- 3
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 28
- num Events
- 1
- group Id
- EG006
- num Affected
- 2
- num At Risk
- 17
- num Events
- 2
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 14
- num Events
- 1
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 6
- num At Risk
- 23
- num Events
- 6
- group Id
- EG010
- num Affected
- 1
- num At Risk
- 8
- num Events
- 1
- term
- Cough
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 8
- num Events
- 1
- group Id
- EG001
- num Affected
- 10
- num At Risk
- 44
- num Events
- 10
- group Id
- EG002
- num Affected
- 7
- num At Risk
- 25
- num Events
- 7
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG004
- num Affected
- 2
- num At Risk
- 7
- num Events
- 2
- group Id
- EG005
- num Affected
- 3
- num At Risk
- 28
- num Events
- 3
- group Id
- EG006
- num Affected
- 2
- num At Risk
- 17
- num Events
- 2
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- COVID-19
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 8
- num Events
- 1
- group Id
- EG001
- num Affected
- 19
- num At Risk
- 44
- num Events
- 19
- group Id
- EG002
- num Affected
- 8
- num At Risk
- 25
- num Events
- 8
- group Id
- EG003
- num Affected
- 3
- num At Risk
- 6
- num Events
- 3
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 10
- num At Risk
- 28
- num Events
- 10
- group Id
- EG006
- num Affected
- 7
- num At Risk
- 17
- num Events
- 7
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 10
- num At Risk
- 23
- num Events
- 10
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Decreased appetite
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 8
- num Events
- 1
- group Id
- EG001
- num Affected
- 19
- num At Risk
- 44
- num Events
- 19
- group Id
- EG002
- num Affected
- 6
- num At Risk
- 25
- num Events
- 6
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 6
- num Events
- 2
- group Id
- EG004
- num Affected
- 2
- num At Risk
- 7
- num Events
- 2
- group Id
- EG005
- num Affected
- 10
- num At Risk
- 28
- num Events
- 10
- group Id
- EG006
- num Affected
- 5
- num At Risk
- 17
- num Events
- 5
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Diarrhea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 44
- num Events
- 3
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG004
- num Affected
- 2
- num At Risk
- 7
- num Events
- 2
- group Id
- EG005
- num Affected
- 8
- num At Risk
- 28
- num Events
- 8
- group Id
- EG006
- num Affected
- 4
- num At Risk
- 17
- num Events
- 4
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 6
- num At Risk
- 23
- num Events
- 6
- group Id
- EG010
- num Affected
- 2
- num At Risk
- 8
- num Events
- 2
- term
- Edema peripheral
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 8
- num Events
- 2
- group Id
- EG001
- num Affected
- 17
- num At Risk
- 44
- num Events
- 17
- group Id
- EG002
- num Affected
- 6
- num At Risk
- 25
- num Events
- 6
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 6
- num Events
- 2
- group Id
- EG004
- num Affected
- 7
- num At Risk
- 7
- num Events
- 7
- group Id
- EG005
- num Affected
- 18
- num At Risk
- 28
- num Events
- 18
- group Id
- EG006
- num Affected
- 11
- num At Risk
- 17
- num Events
- 11
- group Id
- EG007
- num Affected
- 2
- num At Risk
- 14
- num Events
- 2
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 11
- num At Risk
- 23
- num Events
- 11
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Fatigue
- serious Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 44
- num Events
- 2
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 28
- num Events
- 1
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Febrile neutropenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 44
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 28
- num Events
- 1
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 17
- num Events
- 1
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Anemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 8
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 44
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 28
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Blood loss anemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 44
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 28
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Thrombocytopenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 44
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 28
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Atrial fibrillation
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Endocrine disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 44
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 28
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 23
- num Events
- 1
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Hypophysitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 44
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 25
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 28
- num Events
- 0
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 17
- num Events
- 1
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Gastric haemorrhage
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 44
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 25
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 28
- num Events
- 1
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 17
- num Events
- 1
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Gastrointestinal haemorrhage
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 44
- num Events
- 0
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 25
- num Events
- 2
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 28
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Obstruction gastric
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 44
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 28
- num Events
- 1
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Small intestinal obstruction
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 44
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 28
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 14
- num Events
- 1
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 23
- num Events
- 1
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Abdominal pain upper
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE v5.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 44
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 25
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 28
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 14
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 5
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 23
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 8
- num Events
- 0
- term
- Anal fistula
- time Frame
- Up to 30 days from the last dose of TTX-030, a maximum duration of 2 years of treatment
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle